Cited by 55Gene expression and cancer classificationCancer Diagnosis and TreatmentBreast Cancer Treatment Studies

Deep learning-based pan-cancer classification model reveals tissue-of-origin specific gene expression signatures

Open access
Divate, Mayur, Tyagi, Aayush, Richard, Derek J., Prasad, Prathosh A., Gowda, Harsha, Nagaraj, Shivashankar H.·2022·Cancers

Published version of a preprint

Abstract

Cancer tissue-of-origin specific biomarkers are needed for effective diagnosis, monitoring, and treatment of cancers. In this study, we analyzed transcriptomics data from 37 cancer types provided by The Cancer Genome Atlas (TCGA) to identify cancer tissue-of-origin specific gene expression signatures. We developed a deep neural network model to classify cancers based on gene expression data. The model achieved a predictive accuracy of >97% across cancer types indicating the presence of distinct cancer tissue-of-origin specific gene expression signatures. We interpreted the model using Shapley additive explanations to identify specific gene signatures that significantly contributed to cancer-type classification. We evaluated the model and the validity of gene signatures using an independent test data set from the International Cancer Genome Consortium. In conclusion, we present a robust neural network model for accurate classification of cancers based on gene expression data and also provide a list of gene signatures that are valuable for developing biomarker panels for determining cancer tissue-of-origin. These gene signatures serve as valuable biomarkers for determining tissue-of-origin for cancers of unknown primary.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers14051185

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Transcriptomic-based algorithms for cell-of-origin prediction have been developed, but they require expansion of clinical transcriptome profiling for generalizability assessments.

    “Transcriptomic-based algorithms have also been developed (136, 137), although these approaches will require expansion of clinical transcriptome profiling for assessments of generalizability.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Divate, M., Tyagi, A., Richard, D. J., Prasad, P. A., Gowda, H., & Nagaraj, S. H.
Affiliations
  • Queensland University of Technology (AU)
  • Indian Institute of Technology Delhi (IN)
  • Translational Research Institute (AU)
  • Indian Institute of Science Bangalore (IN)
Corresponding author
  • Gowda, Harsha
  • Nagaraj, Shivashankar H.
Venue
Cancers
Publisher
MDPI AG
Published
2022-02-24
Volume
14
Issue
5
Pages
1185
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4214618644
Cited by
55
References
46
Citations by year
2026: 11 · 2025: 16 · 2024: 16 · 2023: 8 · 2022: 4
FWCI
3.57
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NOT FOUND REPOSITORY (Indian Institute of Science Bangalore) (acceptedVersion)
  • QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Health Sciences › Medicine › Oncology › Cancer Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
pan-cancer classification, tissue of origin, gene expression signatures, cancer of unknown primary, biomarker panel, deep neural network, SHAP, transcriptomics, TCGA, ICGC, cancer diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review